Comunicación corta
Respuesta favorable a rituximab de un linfoma primario de anejos oculares
Favourable response to rituximab by an ocular adnexal primary lymphoma
Leído
189
Vecesse ha leído el artículo
23
Total PDF
166
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2023 3 | 1 | 0 | 1 |
| 2021 5 | 1 | 2 | 3 |
| 2020 6 | 1 | 0 | 1 |
| 2020 4 | 1 | 0 | 1 |
| 2019 4 | 1 | 2 | 3 |
| 2018 2 | 12 | 0 | 12 |
| 2018 1 | 9 | 1 | 10 |
| 2017 12 | 7 | 1 | 8 |
| 2017 11 | 16 | 1 | 17 |
| 2017 10 | 11 | 5 | 16 |
| 2017 9 | 5 | 1 | 6 |
| 2017 8 | 10 | 2 | 12 |
| 2017 7 | 12 | 2 | 14 |
| 2017 6 | 15 | 2 | 17 |
| 2017 5 | 27 | 1 | 28 |
| 2017 4 | 0 | 0 | 0 |
| 2017 3 | 0 | 1 | 1 |
| 2016 1 | 2 | 0 | 2 |
| 2016 12 | 3 | 0 | 3 |
| 2016 11 | 24 | 0 | 24 |
| 2016 10 | 7 | 0 | 7 |
| 2016 8 | 0 | 1 | 1 |
| 2016 7 | 1 | 1 | 2 |
Mostrar todo
